About HERS

Women’s Health Does Not Move Forward in Silos

The conversation around women’s health has changed quickly. The harder question now is what happens next: which ideas get funded, which technologies hold up in the clinic, which therapies make it through development, and which companies can turn good science into something patients can actually use. Those questions cut across investment, research, technology, drug development, and healthcare, which is exactly where HERS comes in.

HERS: Health Executive & Research Summit brings together the people working across women’s health to share ideas, make connections, and move promising science, technologies, and companies forward. Investors, entrepreneurs, pharma and biotech leaders, MedTech innovators, researchers, clinicians, healthcare executives, and strategic partners come together to learn from one another and get a broader view of what is happening across the field.

A promising therapy needs strong science, funding, clinical development, and a path to patients. A new device or diagnostic needs validation, investment, reimbursement, and adoption. A startup needs capital, partners, and a clear understanding of the market. HERS brings those conversations together.

Join us April 12-14, 2027 in San Diego for the 2nd Annual HERS: Health Executive & Research Summit.

Three Comprehensive Programs

HERS brings together three programs that look at women’s health from different, but closely connected, perspectives. Attendees can follow the program most relevant to their work while also connecting with people across investment, technology, drug development, research, and healthcare.

Hear from Leaders Across Women’s Health

HERS brings together people working on women’s health from very different perspectives. The inaugural faculty included senior leaders from organizations including CVS Health, Genentech, Eli Lilly, Merck, Organon, Roche Diagnostics, HSBC, Illumina Ventures, leading health systems and research institutions, venture firms, and emerging women’s health companies.

That mix matters. Investors hear directly from scientists and entrepreneurs developing new therapies and technologies. Researchers and drug developers get a better understanding of the funding and commercialization environment. Health system leaders, clinicians, founders, and industry executives can compare what they are seeing and find places where their work overlaps.

For 2027, HERS will once again bring together leaders across Venture and Innovation, MedTech, and Therapeutics for candid conversations about where women’s health stands, what still needs to change, and where the strongest opportunities are.

See Who Spoke at HERS 2026 or Apply to Speak on the 2027 Program

Who You’ll Meet

HERS brings together people from across the women’s health ecosystem, including:

• Investors and venture capitalists
• Entrepreneurs, founders, and emerging companies
• Pharma and biotech scientists and R&D leaders
• MedTech, diagnostics, and digital health innovators
• Clinicians and healthcare providers
• Health system executives
• Academic and translational researchers
• Payers and market access leaders
• Regulatory and medical affairs professionals
• Strategic partners and industry collaborators

The inaugural HERS community reflected that same range, with investors, founders, scientists, clinicians, technologists, healthcare executives, and other stakeholders taking part.

View the 2026 Attendee List

Be Part of HERS 2027

Join us April 12-14, 2027 in San Diego for three days of conversation, new connections, and fresh perspectives across women’s health investment, MedTech, and therapeutics.

Register

Programs